Michele Marino

Michele Marino

Auto-generated profile, based on publicly available information

Michele Marino

Laboratorio MYLAV, 20017 Milan, Italy

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Journal of Veterinary Diagnostic Investigation
Verified
Journal Article
Open access
PDF file
ANArturo Nicoletti
Arturo Nicoletti
LALuca Aresu
Luca Aresu
MMMichele Marino
Michele Marino
MMMaria Massaro
Maria Massaro
EMEugenio Martignani
Eugenio Martignani
CGCecilia Gola
Cecilia Gola
A 7-y-old mixed-breed male dog was presented with a history of generalized lymphadenopathy. Fine-needle aspirates of the enlarged peripheral lymph nodes were suggestive of lymphoma. Histologic examination of a retromandibular lymph node was suggestive of high-grade, medium large-cell lymphoma. Immunohistochemistry revealed concurrent expression of CD3 and CD20. The co-localization of the 2 antigens was confirmed by immunofluorescence. PCR for antigen receptor gene rearrangements (PARR) detected clonal rearrangements for both T-cell receptor gamma and B-cell receptor. The final diagnosis was CD3-CD20–positive anaplastic lymphoma with cross-lineage rearrangement.

11 January 2022 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
FAFrancesco Albanese
Francesco Albanese
FAFrancesca Abramo
Francesca Abramo
MMMichele Marino
Michele Marino
MMMaria Massaro
Maria Massaro
LMLaura Marconato
Laura Marconato
LALuca Aresu
Luca Aresu
Cutaneous lymphocytosis (CL) is an uncommon and controversial lymphoproliferative disorder described in dogs and cats. CL is generally characterized by a heterogeneous clinical presentation and histological features that may overlap with epitheliotropic lymphoma. Therefore, its neoplastic or reactive nature is still debated. Here, we describe clinicopathological, immunohistochemical, and clonality features of a retrospective case series of 19 cats and 10 dogs with lesions histologically compatible with CL. In both species, alopecia, erythema, and scales were the most frequent clinical signs. Histologically, a dermal infiltrate of small to medium-sized lymphocytes, occasionally extending to the subcutis, was always identified. Conversely, when present, epitheliotropism was generally mild. In cats, the infiltrate was consistently CD3+; in dogs, a mixture of CD3+ and CD20+ lymphocytes was observed only in 4 cases. The infiltrate was polyclonal in all cats, while BCR and TCR clonal rearrangements were identified in dogs. Overall, cats had a long-term survival (median overall survival = 1080 days) regardless of the treatment received, while dogs showed a shorter and variable clinical course, with no evident associations with clinicopathological features. In conclusion, our results support a reactive nature of the disease in cats, associated with prolonged survival; despite a similar histological picture, canine CL is associated with a more heterogeneous lymphocytic infiltrate, clonality results, and response to treatment, implying a more challenging discrimination between CL and CEL in this species. A complete diagnostic workup and detailed follow-up information on a higher number of cases is warrant for dogs.

1 January 2015
Verified
Book Chapter
Closed access
ACAntonio Camarda
Antonio Camarda
ECElena Circella
Elena Circella
APAntonia Pupillo
Antonia Pupillo
MLMarilisa Legretto
Marilisa Legretto
MMMichele Marino
Michele Marino
NPNicola Pugliese
Nicola Pugliese

1 December 2020 in Veterinary Parasitology: Regional Studies and Reports
Verified
Journal Article
Closed access
RFRoberta Franchi
Roberta Franchi
WBWalter Bertazzolo
Walter Bertazzolo
MMMichele Marino
Michele Marino
BMBarbara De Marco
Barbara De Marco

26 September 2015 in Annals of Oncology
Verified
Journal Article
Closed access
PDF file
MOMargaret Ottaviano
Margaret Ottaviano
VDV. Damiano
V. Damiano
LNLucia Nappi
Lucia Nappi
PRPasquale Rescigno
Pasquale Rescigno
LMLiliana Montella
Liliana Montella
GPGiovannella Palmieri
Giovannella Palmieri
Background: Thymic epithelial tumors (TETs) are rare neoplasms characterized by histological variability. Several biological agents have been evaluated in TETs in small phase II trials. Efficacy of octreotide/lanreotide with or without prednisone in TETs OctreoScan positive has been widely demonstrated in thymoma, but no clearly in thymic carcinoma.